These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 30604908

  • 1. TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients.
    Zhang X, Han S, Zhou H, Cai L, Li J, Liu N, Liu Y, Wang L, Fan C, Li A, Miao Y.
    Mol Carcinog; 2019 May; 58(5):767-776. PubMed ID: 30604908
    [Abstract] [Full Text] [Related]

  • 2. CCDC85B promotes non-small cell lung cancer cell proliferation and invasion.
    Feng Y, Gao Y, Yu J, Jiang G, Zhang X, Lin X, Han Q, Rong X, Xu H, Li Q, Qiu X, Wang E.
    Mol Carcinog; 2019 Jan; 58(1):126-134. PubMed ID: 30242906
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.
    Li A, Zhang W, Xia H, Miao Y, Zhou H, Zhang X, Dong Q, Li Q, Qiu X, Wang E.
    Tumour Biol; 2016 Nov; 37(11):15157-15164. PubMed ID: 27677288
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S, Depner S, Dvornikov D, Merkle R, Szczygieł M, Müller-Decker K, Lucarelli P, Wäsch M, Mairbäurl H, Rabe KF, Kugler C, Vollmer E, Reck M, Scheufele S, Kröger M, Ammerpohl O, Siebert R, Goldmann T, Klingmüller U.
    Cancer Res; 2016 Jul 01; 76(13):3785-801. PubMed ID: 27197161
    [Abstract] [Full Text] [Related]

  • 12. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer.
    Gao J, Qiu X, Xi G, Liu H, Zhang F, Lv T, Song Y.
    Oncol Rep; 2018 Oct 01; 40(4):1971-1984. PubMed ID: 30106450
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
    Wang X, Sun Q, Chen C, Yin R, Huang X, Wang X, Shi R, Xu L, Ren B.
    Oncotarget; 2016 Feb 16; 7(7):8029-42. PubMed ID: 26771237
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
    Xing R, Chen KB, Xuan Y, Feng C, Xue M, Zeng YC.
    Surg Oncol; 2016 Sep 16; 25(3):147-51. PubMed ID: 27566015
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer.
    Guo Z, Peng G, Li E, Xi S, Zhang Y, Li Y, Lin X, Li G, Wu Q, He J.
    Sci Rep; 2017 Sep 06; 7(1):10612. PubMed ID: 28878291
    [Abstract] [Full Text] [Related]

  • 20. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R, Zhong T, Dang Y, Zhang X, Li P, Chen G.
    Clin Transl Oncol; 2016 Apr 06; 18(4):360-8. PubMed ID: 26307752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.